We show that a cohort of ALS patients had higher than normal IgG1 antibody to ATCV-1, degradation of motor performance is accelerated in ATCV-1 challenged SOD1-G93A transgenic mice. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.